By vgreene, 11 March, 2015 Exclude Patient Type Detail Header No Detail Type Text Detail Text After initial 3-5 yrs of tx, do comprehensive risk assessment (hx, incl. intercurrent fxs and new chronic conditions, med list, √ BMD, √ ht; if ht↓, then √ vertebral imaging)<sup>63</sup> If high fx risk: consider continued tx w/ bisphosphonate or alternative tx<sup>63,64</sup> If modest fx risk after initial tx: reasonable to d/c bisphosphonates<sup>64</sup> after 3-5 yrs. If d/c meds: Monitor serially for fx/falls/new chronic diseases; consider serial BMD, biochemical markers, vertebral imaging If considering “drug holiday”: re-√ vertebral imaging, as med d/c not recommended if recent vertebral fx. Biochemical markers<sup>62</sup> may help determine “drug-holiday” duration